LEADER 01925nam  2200589Ia 450 
001 9910450032203321
005 20200520144314.0
010   $a1-280-17651-2
010   $a9786610176519
010   $a0-309-52950-6
035   $a(CKB)1000000000005580
035   $a(OCoLC)60779272
035   $a(CaPaEBR)ebrary10060413
035   $a(SSID)ssj0000282322
035   $a(PQKBManifestationID)11194843
035   $a(PQKBTitleCode)TC0000282322
035   $a(PQKBWorkID)10326504
035   $a(PQKB)11574234
035   $a(MiAaPQ)EBC3564046
035   $a(Au-PeEL)EBL3564046
035   $a(CaPaEBR)ebr10060413
035   $a(CaONFJC)MIL17651
035   $a(EXLCZ)991000000000005580
100   $a20040925d2004      my             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aNew treatments for addiction$b[electronic resource] $ebehavioral, ethical, legal, and social questions /$fCommittee on Immunotherapies and Sustained-Release formations for Treating Drug Addiction ; Henrick J. Harwood and Tracy G. Myers, editors
210   $aWashington, D.C. $cNational Academies Press$dc2004
215   $a1 online resource (320 p.)
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-09128-4 
320   $aIncludes bibliographical references.
606   $aSubstance abuse$xTreatment
606   $aSubstance abuse$xChemotherapy
606   $aImmunotherapy
608   $aElectronic books.
615  0$aSubstance abuse$xTreatment.
615  0$aSubstance abuse$xChemotherapy.
615  0$aImmunotherapy.
676   $a616.86/061
701   $aHarwood$b Henrick J$0857740
701   $aMyers$b Tracy G$0938426
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910450032203321
996   $aNew treatments for addiction$92114268
997   $aUNINA